BENJAMIN SELL: Open Payments
NPI 1144782293 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$537 in 21 payments from 12 companies in 2025. Trend: 2023 $667 · 2024 $717 · 2025 $537
Food & beverage: $537
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $154 |
| Ferring Pharmaceuticals Inc. | 3 | $65 |
| Dendreon Pharmaceuticals LLC | 2 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Blue Earth Diagnostics | 1 | $35 |
| Merck Sharp & Dohme LLC | 1 | $32 |
| Medtronic, Inc. | 1 | $30 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Endo USA, Inc. | 1 | $24 |
Products named: XTANDI, ADSTILADRIN, PROVENGE, Nubeqa, POSLUMA, KEYTRUDA, INCEPTIV, PYLARIFY.
Industry payments across AZ — which companies pay providers there.
